Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.

Antioxidants may be a beneficial treatment for an inherited genetic disorder.

Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.

A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure.